A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation

G S Hobbs; N Kaur; P Hilden; D Ponce; C Cho; H R Castro-Malaspina; S Giralt; J D Goldberg; A A Jakubowski; E B Papadopoulos; C Sauter; G Koehne; J Yahalom; S Delvin; J N Barker; M-A Perales

doi:10.1038/bmt.2016.36

A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation

Bone Marrow Transplant. 2016 Jul;51(7):1010-2. doi: 10.1038/bmt.2016.36. Epub 2016 Mar 14.

Authors

G S Hobbs^{1

2

3}, N Kaur¹, P Hilden⁴, D Ponce^{1

2}, C Cho^{1

2}, H R Castro-Malaspina^{1

2}, S Giralt^{1

2}, J D Goldberg^{1

2}, A A Jakubowski^{1

2}, E B Papadopoulos^{1

2}, C Sauter^{1

2}, G Koehne^{1

2}, J Yahalom^{2

5}, S Delvin^{2

4}, J N Barker^{1

2}, M-A Perales^{1

2}

Affiliations

¹ Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, Department of Medicine, New York, NY, USA.
² Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
³ Harvard Medical School, Boston, MA, USA.
⁴ Memorial Sloan Kettering Cancer Center, Department of Biostatistics and Epidemiology, New York, NY, USA.
⁵ Memorial Sloan Kettering Cancer Center, Department of Radiation Oncology, New York, NY, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Adult
Aged
Female
Graft vs Host Disease
Hematologic Neoplasms / therapy*
Hematopoietic Stem Cell Transplantation / methods*
Humans
Male
Middle Aged
Neutrophils / cytology
Risk
Time Factors
Transplantation Conditioning / methods*
Transplantation, Homologous / methods
Treatment Outcome

Publication types

MeSH terms

Grants and funding